Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease.
Langrish CL, Bradshaw JM, Francesco MR, Owens TD, Xing Y, Shu J, LaStant J, Bisconte A, Outerbridge C, White SD, Hill RJ, Brameld KA, Goldstein DM, Nunn PA. Langrish CL, et al. Among authors: bradshaw jm. J Immunol. 2021 Apr 1;206(7):1454-1468. doi: 10.4049/jimmunol.2001130. Epub 2021 Mar 5. J Immunol. 2021. PMID: 33674445 Free PMC article.
The Proteome-Wide Potential for Reversible Covalency at Cysteine.
Senkane K, Vinogradova EV, Suciu RM, Crowley VM, Zaro BW, Bradshaw JM, Brameld KA, Cravatt BF. Senkane K, et al. Among authors: bradshaw jm. Angew Chem Int Ed Engl. 2019 Aug 12;58(33):11385-11389. doi: 10.1002/anie.201905829. Epub 2019 Jul 5. Angew Chem Int Ed Engl. 2019. PMID: 31222866 Free PMC article.
Gestational Diabetes and Childhood Obesity.
Bradshaw JM, Ensor SJA, Lorenz HAL. Bradshaw JM, et al. JAMA. 2019 Feb 19;321(7):708. doi: 10.1001/jama.2018.19750. JAMA. 2019. PMID: 30778593 No abstract available.
Underestimating the true impact of obesity.
Bradshaw JM, Ensor S, Lorenz H, Spence C, Hucker G. Bradshaw JM, et al. Lancet Public Health. 2019 Jan;4(1):e16. doi: 10.1016/S2468-2667(18)30257-3. Lancet Public Health. 2019. PMID: 30621935 Free article. No abstract available.
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma.
Nairismägi M-, Gerritsen ME, Li ZM, Wijaya GC, Chia BKH, Laurensia Y, Lim JQ, Yeoh KW, Yao XS, Pang WL, Bisconte A, Hill RJ, Bradshaw JM, Huang D, Song TLL, Ng CCY, Rajasegaran V, Tang T, Tang QQ, Xia XJ, Kang TB, Teh BT, Lim ST, Ong CK, Tan J. Nairismägi M-, et al. Among authors: bradshaw jm. Leukemia. 2018 May;32(5):1147-1156. doi: 10.1038/s41375-017-0004-x. Epub 2018 Feb 2. Leukemia. 2018. PMID: 29434279 Free PMC article.
The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug Clearance.
Venetsanakos E, Brameld KA, Phan VT, Verner E, Owens TD, Xing Y, Tam D, LaStant J, Leung K, Karr DE, Hill RJ, Gerritsen ME, Goldstein DM, Funk JO, Bradshaw JM. Venetsanakos E, et al. Among authors: bradshaw jm. Mol Cancer Ther. 2017 Dec;16(12):2668-2676. doi: 10.1158/1535-7163.MCT-17-0309. Epub 2017 Oct 4. Mol Cancer Ther. 2017. PMID: 28978721 Free article.
63 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page